A comparison of the memory and exhaustion gene scores associated with CD8+ T cells from AML bone marrow with those from CD8+ TILs isolated from solid tumors, in which ipilimumab demonstrates high clinical activity, revealed higher exhaustion profiles and checkpoint expression in solid tumor-derived T cells[60]. Here, CD8A is linked to acute myeloid leukemia.